Possible Impact of Impaired Double-stranded RNA Degradation and Nitrosative Stress on Immuno-inflammatory Cascade in Type 2 Diabetes

Abstract

The immune response can be triggered by molecules derived from microorganisms (PAMP) or from molecules derived from damaged or dead host cells, known as the damage-associated molecular-pattern molecules (DAMP). Their immune effects are accompanied by altered redox environment. The level of stable end products of nitric oxide (NO)- plasma nitrate and nitrite (NOx), carbonyl groups (PCO) and nitrotyrosine (NTY), in relation to the metabolism of dsRNAs (poly I:C and poly A:U) and xanthine oxidase (XO activity), in plasma of type2 diabetic patients was determined. Thirty-six patients with type 2 diabetes (age group 34–66 years, 19 male and 17 female) were allocated to the study. Diabetic patients had a significantly higher level of plasma NOx products, NTY and PCO, fructosamine (FA) and XO activity indicating about altered redox environment. The concentration of circulating ribonucleic acids (CNAs) was significantly higher in type 2 diabetic patients, which was accompanied by a significantly decreased activity of RNase against double stranded RNA forms (poly I:C and poly A:U), compared to control samples. To determine whether CNAs, as possible DAMP molecules, are capable of exerting effect on inflammatory and host antiviral response, the effect of isolated CNAs on NF-κB, Bcl-2, Bax, MDA-5 and IRF-3 regulation was evaluated in culture of fresh isolated thymocytes. Circulating nucleic acids isolated from type 2 diabetic patients were able to upregulate NF-κB more than control RNA samples. In the same experimental conditions the mild Bcl-2 upregulation, followed by the marked Bax upregulation, was demonstrated. Since the Bcl-2/Bax ratio was lower in type 2 diabetic samples, obtained results may implicate that CNAs may exert proapoptotic response in type 2 diabetes. The CNAs isolated from diabetic patients were able to downregulate MDA-5 and IRF-3, very important subjects of the surveillance and cellular anti-viral response. The major findings of the present study are that impaired dsRNA metabolism may lead to increased level of different sized RNAs in type 2 diabetic patients. Acting as possible DAMP molecules, they may contribute to higher susceptibility of immune cells to inflammatory cascade via NF-κB activation, and possible MDA-5/IRF-3 axis downregulation, what may have an influence on further ineffective response against different pathogens.

Key words

Nitric oxide (NO) - carbonyl groups - Rnase - circulating nucleic acids (CNAs) xanthine oxidase (XO) - type 2 diabetes - NF-κB - Bcl-2 - Bax - MDA-5 - IRF-3

References

• 1 Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders.  Nutr Rev. 2007;  65 S152-156
• 2 Duncan BB, Schmidt MI, Pankow JS. et al . Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes.  Diabetes. 2003;  52 1799-1805
• 3 Tsan MF, Gao B. Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors.  J Endotox Res. 2007;  13 ((1)) 6-14
• 4 Foell D, Wittkowski H, Roth J. Mechanisms of disease: a ‘DAMP’ view of inflammatory arthritis.  Nat Clin Pract Rheumatol. 2007;  3 ((7)) 382-390
• 5 Lotze MT, Zeh HJ, Rubartelli A. et al . The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.  Immunol Rev. 2007;  220 ((1)) 60-81
• 6 Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.  Trends in Immunology. 2007;  28 ((10)) 429-436
• 7 Suzuki K, Mori A, Ishi KJ. et al . Activation of target tissue immune recognition molecules by double-stranded polynucleotides.  Proc Natl Acad Sci USA. 1999;  96 2285-2290
• 8 Devendra D, Jasinski J, Melanitou E. et al . Interferon-α as a Mediator of Polyinosinic:polycytidylic acid–induced type 1 diabetes.  Diabetes. 2005;  54 2549-2556
• 9 Doukas J, Cutler AH, Mordes JP. Polyinosinic:polycytidylic acid is a potent activator of endothelial cells.  Am J Pathol. 1994;  145 137-147
• 10 Faruqi TR, DiCorleto PE. IFN-gamma inhibits double-stranded RNA-induced E-selectin expression in human endothelial cells.  J Immunol. 1997;  159 3989-3994
• 11 Moriyama H, Wen L, Abiru N. et al . Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidilyc acid) and jan insulin sellf-peptide.  Proc Natl Acad Sci. 2002;  99 5539-5544
• 12 Rhodes CJ, Taylor KW. Effect of interferon and double-stranded RNA on ß-cell function in mouse islets of Langerhans.  Biochem J. 1985;  228 87-94
• 13 Heitmeier MR, Scarim AL, Corbett JA. Double-stranded RNA inhibits ß-cell function and induces islet damage by stimulating ß-cell production of nitric oxide.  J Biol Chem. 1999;  274 12531-12536
• 14 Liu D, Darville M, Eizirik DL. Double-stranded ribonucleic acid (RNA) Induces ß-cell fas messenger RNA expression and increases cytokine-induced ß-cell apoptosis.  Endocrinology. 2001;  142 2593-2599
• 15 Scarim AL, Arnush M, Blair LA. et al . Mechanisms of ß-Cell death in response to double-stranded (ds) RNA and Interferon-γ dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.  Am J Pathol. 2001;  159 273-283
• 16 Diebold SS, Kaisho T, Hemmi H. et al . Innate antiviral responses by means of TLR7-meiated recognition of single stranded RNA.  Science. 2004;  303 1529-1531
• 17 Guvener M, Pasaoglu I, Demircin M. et al . Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting.  Endocr J. 2002;  49 ((5)) 531-537
• 18 Ocak S, Duran N, Kaya H. et al . Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis.  Int J Clin Pract. 2006;  60 ((6)) 670-674
• 19 Hiroki K, Osamu T, Shintaro S. et al . Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.  Nature. 2006;  441 ((7089)) 101-105
• 20 Kang D, Gopalkrishnan RV, Wu Q. et al . mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.  Proc Natl Acad Sci USA. 2002;  99 ((2)) 637-642
• 21 Hiscott J. Triggering the innate antiviral response through IRF-3 Activation.  J Biol Chem. 2007;  282 ((21)) 15325-15329
• 22 Yeow WS, Au WC, Lowther WJ. et al . Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cells.  J Virol. 2001;  75 ((6)) 3021-3027
• 23 Gitlin L, Barchet W, Gilfillan S. et al . Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus.  Proc Natl Acad Sci USA. 2006;  103 ((22)) 8459-8464
• 24 Kocic G, Bjelakovic G, Saranac Lj. et al . Possible impact of plasma RNase activity on immune dysfunction in juvenile diabetes mellitus.  Pediatr Diab. 2005;  6 155-160
• 25 Kocic G, Bjelakovic G, Saranac Lj. et al . Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients.  Diab Res Clin Pract. 2008;  79 204-213
• 26 Navarro-Gonzales JA, Garcia-Benayas C, Arenos J. Semiautomated measurement of nitrate in biological fluids.  Clin Chem. 1998;  44 679-682
• 27 Oliver CN, Ahn B, Moerenman EJ. et al . Age-related changes in oxidized proteins.  J Biol Chem. 1987;  262 5488-5491
• 28 Tien M, Berlett BS, Levine RL. et al . Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentartion: pH dependence of carbonyl formation, tyrosine nitration and methionine oxidation.  Proc Natl Acad Sci USA. 1999;  96 7809-7814
• 29 Baker JR, Zyzak DV, Thorpe SR. et al . Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction.  Clin Chem. 1993;  39 2460-2465
• 30 Kizaki H, Sakurada T. Simple micro-assay methods for enzymes of purine metabolism.  J Lab Clin Med. 1977;  89 1135-1144
• 31 Pavlovic V, Cekic S, Kociæ G. et al . Effect of monosodium glutamate on apoptosis and Bcl-2/Bax protein level in rat thymocyte culture.  Physiol Res. 2007;  56 619-626
• 32 Ceriello A. Oxidative stress and diabetes-associated complications.  Endocr Pract. 2006;  12 ((Suppl 1)) 60-62
• 33 Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy.  Diab Care. 2003;  26 1589-1596
• 34 Tak PP, Gary S, Firestein GS. NF-κB: a key role in inflammatory diseases.  Clin Invest. 2001;  107 ((1)) 7-11
• 35 Hibbs JB. Synthesis of nitric oxide from l-arginine – a recently discovered pathway induced by cytokines with antitumor and antimicrobial activity.  Res Immunol. 1991;  142 565-569
• 36 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide – physiology, pathophysiology, and pharmacology.  Pharmacol Rev. 1991;  43 109-142
• 37 Butler AR, Williams DHL. The physiological role of nitric oxide.  J Chem Soc Rev. 1993;  22 233-241
• 38 Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease.  Prog Cardiovas Dis. 1995;  38 105-128
• 39 Huie RE, Padmaja S. The reaction of NO with superoxide Free Radic.  Res Commun. 1993;  18 195-199
• 40 Pavlovic D, Kocic R, Kocic G. et al . Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes.  Diabetes Obes Metab. 2000;  2 251-256
• 41 Lapolla A, Piarulli F, Sartore G. et al . Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease.  Diab Care. 2007;  30 670-676
• 42 Kocic G, Bjelakovic G, Pavlovic R. et al . Nitrosative stress and its relation to paramethers of diabetic control in the early stages of Type 1 diabetes.  Diab Metab. 2003;  29 4S210
• 43 Esposito K, Ciotola M, Schisano B. et al . Oxidative stress in the metabolic syndromeOxidative stress in the metabolic syndrome.  J Endocrinol Invest. 2006;  29 791-795
• 44 Stamler JS, Simon DI, Osbourne JA. et al . S-Nitrosylation of proteins with nitric oxide – synthesis and characterization of biologically active compounds.  Proc Natl Acad Sci USA. 1992;  89 444-448
• 45 Cote CG, Yu FS, Zulueta JJ. et al . Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide.  Am J Physiol. 1996;  271 ((Lung Cell Mol Physiol 15)) L869-L874
• 46 White CR, darley-Usmar V, Berrington WR. et al . Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits.  Proc Natl Acad Sci USA. 1996;  93 8745-8749
• 47 Connelly L, Jacobs AT, Palacios-Callender M. et al . Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression.  J Biol Chem. 2003;  278 26480-26487
• 48 Connelly L, Palacios-Callender M, Ameixa C. et al . Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide.  J Immunol. 2001;  166 3873-3881
• 49 Ahn KS, Sethi G, Aggarwal BB. Nuclear factor-kappa B: from clone to clinic.  Curr Mol Med. 2007;  7 619-637
• 50 Reimer T, Brcic M, Schweizer M. et al . Poly(I:C) and LPS induce distinct IRF3 and NF-κB signaling during type-I IFN and TNF responses in human macrophages.  J Leukocyte Biol. 2008;  83 1249-1257
• 51 Desco MC, Miguel Asensi M, Márquez R. et al . ¹Xanthine oxidase is involved in free radical production in type 1 diabetes.  Protection by Allopurinol Diabetes. 2002;  51 1118-1124
• 52 Ghezzi P, Bianchi PM, Mantovani A. et al . Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers.  Biochem Biophys Res Commun. 1984;  119 144-149
• 53 Pacher P, Nivorozhkin A, Szabo S. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.  Pharmacol Rev. 2006;  58 87-114
• 54 Lu LL, Puri M, Horvath CM. et al . Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of κB Kinaseε (IKKe)/TBK1.  J Biol Chem. 2008;  283 ((21)) 14269-14276
• 55 Devaraj SG, Wang N, Chen Z. et al . Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus.  J Biol Chem. 2007;  282 ((44)) 32208-32221

Correspondence